Prelude Therapeutics, Inc. (PRLD)
3.19
+0.07
(+2.24%)
USD |
NASDAQ |
Mar 19, 16:00
3.22
+0.03
(+0.94%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 200.98M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 332.7% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 19.12 |
| Price to Book Value | 2.928 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2592 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.33% |
Profile
| Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE. |
| URL | http://www.preludetx.com |
| Investor Relations URL | https://investors.preludetx.com/ |
| HQ State/Province | Delaware |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | May. 13, 2026 (est.) |
| Last Earnings Release | Mar. 10, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE. |
| URL | http://www.preludetx.com |
| Investor Relations URL | https://investors.preludetx.com/ |
| HQ State/Province | Delaware |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | May. 13, 2026 (est.) |
| Last Earnings Release | Mar. 10, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |